Drugs and Health Products

On the Health Canada Web site, each navigation section (listed on the left-hand side of the screen) has its own Contact Us page. To find contact information for topics other than Drugs and Health Products, view the Main Contact Us page.

Choose any of these topics for contact information:

• Adverse Reaction Information
• Advisories, Warnings and Recalls
• Biologics, Radiopharmaceuticals & Genetic Therapies
• Compliance and Enforcement
• Controlled Substances & Precursor Chemicals
• Drug Products
• Funding and Fees
• MedEffect Canada
• Medical Devices
• Medical Use of Marihuana
• Natural Health Products
• Public Involvement and Consultation
• Regulatory Requirements for Advertising
• Special Access to Drugs & Health Products
• Veterinary Drugs

Adverse Reaction Information

• Contact the Canada Vigilance Program for information on adverse reactions to the following health products marketed in Canada: pharmaceuticals, biologics (including fractionated blood products as well as therapeutic and diagnostic vaccines), natural health products and radiopharmaceuticals.
• Contact the Health Products and Food Branch Inspectorate for information about medical device problem reporting.
• Contact the Public Health Agency of Canada for information about vaccines.
• Report an Adverse Reaction to Health Canada via a toll-free telephone line or through a Canada Vigilance Regional Office
• Contact the Veterinary Drugs Directorate's Pharmacovigilance program to report adverse reactions to veterinary drugs.

Advisories, Warnings and Recalls

For information about advisories, warning and recalls related to:

• biologics and radiopharmaceuticals for human use contact the Biologics and Genetic Therapies Directorate.
• marketed health products contact the Marketed Health Products Directorate (MHPD).
• pharmaceutical drugs and medical devices for human use contact the Therapeutic Products Directorate (TPD) .
• natural health products contact the Natural Health Products Directorate (NHPD).
• veterinary drugs contact the Veterinary Drugs Directorate (VDD).
  

Biologics, Radiopharmaceuticals and Genetic Therapies

Contact the Biologics and Genetic Therapies Directorate for information about:

• Blood and blood products,
• Cells, tissues and organs,
• Genetic therapies and diagnostics,
• Radiopharmaceuticals
• Reproductive technologies,
• Viral and bacterial vaccines.

For more specific information contact the following offices:

• Centre for Blood and Tissues Evaluation
• Office of Policy and International Collaboration
• Office of Regulatory Affairs
• Donor Semen Special Access Programme

Compliance and Enforcement

Contact the Health Products and Food Branch Inspectorate for information about Health Canada's national compliance and enforcement program for all drugs and health products for human and veterinary use regulated under its mandate. For more specific information contact the following offices:

• Director General's Office
• Inspectorate Ottawa
• Inspectorate Program, Atlantic Region
• Inspectorate Program, Quebec Region
• Inspectorate Program, Ontario Region
• Inspectorate Program, Prairie Region (Manitoba and Saskatchewan)
• Inspectorate Program, Prairie Region (Alberta)
• Inspectorate Program, British Columbia Region

You can submit a complaint of an alleged violation of the Food and Drugs Act and related Regulations with regard to health products

• A consumer complaint is a complaint in which the complainant is a consumer, and typically relates to the perceived effectiveness or safety of a product.
  Register a complaint about a therapeutic product
• A trade complaint is one in which the complainant is often a company or organization or their representative, and typically relates to the activities of a competitor.
  Submit a trade complaint

Controlled Substances and Precursor Chemicals

Contact the Office of Controlled Substances for information on legislation, policy, activities, and the operations with regards to controlled substances and precursor chemicals.

Contact the appropriate DAS Contact Personnel for Police Forces for information on seized drug exhibit submissions.

Drug Products

For information about Drug Products consult the TPD Organization and Telephone List .

Funding and Fees

• For information about Funding and Fees, specifically the Cost Recovery Initiative (CRI), contact the Policy, Planning and International Affairs Directorate.

MedEffect Canada

MedEffect Canada is a Health Canada initiative to provide centralized access to important new health product safety information and to build awareness on adverse reactions and the importance of reporting them.

We invite you to get involved!

• Write to the Marketed Health Products Directorate.
• Contact the Expert Advisory Committee on the Vigilance of Health Products Committee Secretariat.
• Contact the MedEffect Canada Team.
• Contact the Canadian Medical Devices Sentinel Network.
• Contact the Canada Vigilance Program.
• Contact the Canada Vigilance - Medical Device Problem Reporting Program.
• Contact the Canadian Adverse Reaction Newsletter (CARN) Team.
• Contact your Canada Vigilance Regional Office for information or to report an adverse reaction.

We invite you also to:

• Report an adverse reaction
• Subscribe to MedEffect e-Notice or to MedEffect Canada RSS Feeds to receive marketed health product advisories for health professionals and the public as well as the most recent publication of the Canadian Adverse Reaction Newsletter.

Medical Devices

• For information about Medical Devices consult the TPD Organization and Telephone List or Information on Medical Devices

Medical Use of Marihuana

• For information about medical use of marihuana contact the Marihuana Medical Access Division.

Natural Health Products

• Natural Health Product Clinical Trials:
  • Request for contact information for Submission Coordinator
  • Pre-submission meeting requests
  • Inquiries regarding authorization and conduct of human Clinical Trials involving investigational natural health products
• Natural Health Product Ingredients Database Support:
  • Request additions or modifications of Ingredient Information to the NHPD via Issue Form
  • Request additions or modifications of Controlled Vocabulary in the NHPD via Issue Form
• Natural Health Products Online Solution:
  • Inquiries regarding Trading Partner Enrolment
  • To report feedback or technical issues with the NHPD's electronic tools and forms
• Natural Health Product Licensing:
  • Request for contact information for Submission Coordinator
  • Pre-submission meeting requests
  • Product Licence correction requests and PLA withdrawal requests
  • Company information updates
  • To determine if your product meets the definition of a NHP
  • Other inquiries regarding product licensing
• Natural Health Products Site Licensing:
  • Contact information for Submission Coordinator (if unknown)
  • Site Licence correction requests
  • General inquiries regarding site licensing, Good Manufacturing Practices and International Trade Certificates and Foreign Site Reference Number Application Process
• General Inquiries:
  • For general inquiries about natural health products

Public Involvement and Consultation

• For information about public involvement and consultation, contact the Office of Consumer and Public Involvement.

Regulatory Requirements for Advertising

• For information about regulatory requirements for Advertising contact the Regulatory Advertising Section of the Marketed Health Products Directorate.

Special Access to Drugs & Health Products

• For information about special access to drugs contact the Special Access Programme (SAP) - Drugs.
• For information about special access to medical devices contact the Special Access Programme (SAP) - Medical Devices.
• For information about donor semen special access contact the Donor Semen Special Access Programme.

Veterinary Drugs

• For general inquiries about veterinary drugs, contact the Veterinary Drugs Directorate.
• For information about filing submissions and cost recovery, contact the Veterinary Drugs Directorate's Submission and Knowledge Management Division.
• To request an Emergency Drug Release, follow these instructions.